FAYETTEVILE, N.C. (WTVD) -- Fayetteville native John Rowell calls the FDA's approval of the first injectable treatment for HIV pre-exposure prevention, PrEP, "monumental." The FDA said the injectable ...

Long-acting CAB+RPV is preferred by patients for ART due to reduced dosing frequency and stigma, with 89% switching after viral suppression. Studies like PILLAR and EBONI confirm the effectiveness and ...

The federal government says consignments of Lenacapavir, a new drug for HIV prevention, are expected to arrive ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A once-daily pill named PrEP, or pre-exposure prophylaxis, has been a stalwart ...

Uganda has received its first consignment of Lenacapavir, a long-acting HIV prevention injection administered twice a year, ...

Samson Mutua, 27, is the first Kenyan to receive Lenacapavir, a long-acting HIV prevention injection, marking a significant ...

According to UNAIDS, in 2024, about 40.8 million people around the world were living with the human immunodeficiency virus (HIV) — a virus that can lead to acquired immunodeficiency syndrome (AIDS) if ...

(RTTNews) - Gilead Sciences Inc. (GILD) announced that the U.S. Food and Drug Administration has approved Yeztugo (lenacapavir)-the company's injectable HIV-1 capsid inhibitor-as pre-exposure ...

Kenya has received 21,000 doses of the long-acting HIV prevention injection Lenacapavir, with rollout set to begin in March.

Add Yahoo as a preferred source to see more of our stories on Google. a group of fit men in blue and white outfits promote national prep day Today is the first National PrEP Day — a new annual event ...

WHO issued guidelines on July 14, 2025, recommending twice-yearly lenacapavir injections for HIV prevention, raising urgent questions for Nigeria’s response.

Nigeria is set to receive Lenacapavir, a groundbreaking injectable HIV prevention drug, in March 2026. The new PrEP treatment ...